Latest Tax Incentives News

Everest Metals Corporation is issuing $720,000 in Junior Minerals Exploration Incentive credits to shareholders from its recent $2.4 million capital raising, offering a 30% effective tax credit on investments made during FY24.

Neurotech International has secured a $2.44 million R&D tax incentive refund, strengthening its cash position as it advances clinical trials for paediatric neurological disorders and prepares for regulatory submissions in FY2025.

Premier1 Lithium's latest quarterly report reveals multiple high-grade gold assay results at its Yalgoo Project and a successful $1.5 million capital raise, setting the stage for imminent drilling activities.

West Cobar Metals reports significant resource expansions at its Salazar project alongside promising copper-antimony test results at Bulla Park, while aggressively trimming costs to extend its runway.

Magnum Mining and Exploration Limited reported a net cash outflow of $87.68k for Q4 2024, ending the quarter with $332.81k in cash and a substantial $11 million in unused financing facilities.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

Impact Minerals reports a maiden Measured Resource at its Lake Hope High Purity Alumina Project and secures $2.87 million in government funding to accelerate pilot plant development, while progressing exploration and IPO plans for other assets.

Bluechiip Limited reported a $221,000 net cash outflow for Q2 FY2025, with cash reserves dwindling to $121,000. The company has initiated a strategic review and plans a capital raise to secure its future.

Bluechiip Limited advances its strategic repositioning with a new licensing agreement valued up to USD 750,000 alongside ongoing efforts to lift its trading suspension and grow sales.

Terragen Holdings reports robust quarterly progress, highlighted by successful beef feedlot trials and a $4.76 million equity raise, setting the stage for its new probiotic product launch in March 2025.

Cycliq Group Ltd reports a robust Q2 FY2025 with a 15% rise in cash receipts to $1.92 million and strategic leadership appointments aimed at accelerating growth.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.